Albuminar (CSL Behring) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities include increased demand due to rising burn injuries and surgical procedures, driven by urbanization and technological advances. Expanding healthcare infrastructure and strategic partnerships, particularly in Asia-Pacific, offer growth prospects despite tariff challenges impacting pricing and supply chains.

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Albuminar Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets's offering.

The Albuminar market has experienced significant growth, driven by historical clinical use of albumin and its proven efficacy in shock treatment, trauma care, and hospitals' reliance on volume expanders. Looking forward, the market is poised for further expansion due to increasing surgical procedures, growing ICU admissions, rising burn injury cases, and expanding healthcare infrastructure.

The forecast period anticipates several notable trends, such as sustained demand for plasma-derived albumin in emergency care, volume expansion therapy, critical and surgical settings, and adherence to established clinical protocols. Among the key factors steering market growth is the increasing incidence of burn injuries, fueled by household hazards, workplace accidents, and environmental factors like wildfires and industrial mishaps, which, in turn, lead to a higher demand for Albuminar in burn treatment and shock prevention. According to the American Burn Association, 2023 saw a reported 32,540 burn cases, marking a rise from 30,135 cases in 2022.

Additionally, the surge in surgical procedures is another driver of the Albuminar market. Advancements in medical technology, spurred by the prevalence of chronic lifestyle-related diseases, have enhanced the effectiveness and accessibility of surgeries. Albuminar is frequently utilized in surgeries to restore blood volume, maintain circulatory stability, and address hypoalbuminemia, particularly in major trauma cases, cardiac surgeries, liver transplants, and orthopedic operations. The UK Health Security Agency noted that coronary artery bypass graft surgeries reached 27,524 procedures in 2023, underscoring the rising demand for albumin in surgical contexts.

Companies within the Albuminar market are increasingly forming strategic partnerships to enhance technology integration and expand market presence. An example includes Kedrion Biopharma Inc.'s partnership in April 2023, which saw the introduction of a human albumin product in China, bolstering its global position. This collaboration aligns with Kedrion's strategy, supported by a vast network of plasma collection centers.

North America dominated the Albuminar market in 2025, while the Asia-Pacific region is expected to experience the fastest growth. The albuminar market spans regions such as Asia-Pacific, Western and Eastern Europe, North America, South America, the Middle East, and Africa, with countries like Australia, India, China, and the USA at its core.

Despite the growth, tariffs have introduced challenges by escalating costs related to plasma collection and logistics, particularly affecting regions reliant on imported plasma derivatives like Asia-Pacific. However, these tariffs are also creating opportunities for regional plasma fractionation and strengthening domestic supply chains.

For comprehensive insights, the albuminar market research report offers statistics, market size, regional shares, competitive analysis, and trends, essential for thriving in the albuminar industry. This report provides a holistic view of the market dynamics and strategic opportunities available.

Key Topics Covered:

1. Executive Summary
1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market
2. Albuminar Market Characteristics
2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Albuminar Market Attractiveness Scoring and Analysis
3. Albuminar Market Supply Chain Analysis
3.1. Overview of the Supply Chain and Ecosystem
3.2. List of Key Raw Materials, Resources & Suppliers
3.3. List of Major Distributors and Channel Partners
3.4. List of Major End Users
4. Global Albuminar Market Trends and Strategies
4.1. Key Technologies & Future Trends
4.2. Major Trends
5. Albuminar Market Analysis of End Use Industries
5.1. Hospitals
5.2. Surgical Centers
5.3. Trauma Care Units
5.4. Emergency Departments
5.5. Intensive Care Units
6. Albuminar Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, and Covid and Recovery on the Market
7. Global Albuminar Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
7.1. Global Albuminar PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Albuminar Market Size, Comparisons and Growth Rate Analysis
7.3. Global Albuminar Historic Market Size and Growth, 2020-2025, Value ($ Billion)
7.4. Global Albuminar Forecast Market Size and Growth, 2025-2030, 2035F, Value ($ Billion)
8. Global Albuminar Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Albuminar Market Segmentation
9.1. Global Albuminar Market, Segmentation by Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.2. Global Albuminar Market, Segmentation by Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.3. Global Albuminar Market, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Albuminar Market Regional and Country Analysis
10.1. Global Albuminar Market, Split by Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Albuminar Market, Split by Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN10032026004107003653ID1110840633